ebook Munafa Stock Market Course + Intraday & FNO calls  

       

524816 announcements Natco Pharm announcements and dividends declared BSE

Natco Pharm Complete list of announcements declared & dividend announcements by Natco Pharm 524816

Natco Pharm 524816 listed on BSE and deals in

Announcements and dividends declared by Natco Pharm 524816

Natco Pharma, Jindal Saw among 10 stocks with RSI trending down
Dive into the world of stock market analysis as we unravel the significance of the Relative Strength Index (RSI) and its implications for 10 stocks showing a downtrend in RSI. ETMarkets explores why monitoring RSI is crucial for making informed investment
Announcement as on 09 October 2023

Pee Safe raises million in a Series B funding round led by Natco Pharma and Rainmatter Health
Hygiene and wellness brand Pee Safe has raised million in a Series B funding round led by Natco Pharma Limited and Rainmatter Health. The funds will be used to expand the company's retail presence in India, expand overseas, and allocate additional resou
Announcement as on 12 September 2023

Gainers & Losers: Adani Ports, Natco Pharma among 5 stocks in action on Monday
For more such web stories click on the ET icon below
Announcement as on 11 September 2023

Natco Pharma, Celgene Corp, others sued in US for generic cancer drug
Natco Pharma on Friday said the company and other drug makers have been named defendants in an antitrust lawsuit regarding a generic cancer treatment drug in the US. The Hyderabad-based drug firm along with Celgene Corporation, Bristol Myers Squibb, Brecke
Announcement as on 08 September 2023

Natco Pharma, others sued in US for generic cancer drug
The company believes this matter is without merit, Natco Pharma said in a statement. Breckenridge is the abbreviated new drug application (ANDA) holder and distribution partner for the generic product in the US, it added. Natco Pharma shares were trading 3
Announcement as on 08 September 2023

Announcements by Natco Pharm first page | Next page | Prev page |

524816 Natco Pharm current price & indicator signals

Moving Averages for Natco Pharm

  • 5Day Average: 788.24
  • 12Day Average: 802.13
  • 20Day Average: 811.88
  • 50Day Average: 845.83
  • 100Day Average: 893.86
  • 150Day Average: 952.72
  • 200Day Average: 934.86

524816 Indicators & signals

Indicator MACD (12,26,9)

799.06, 815.81, -15.77
Indicator MACD is in negative zone

Indicator ADX (14)

21.05, 13.64, 20.91
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 42
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 524816 Natco Pharm are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
22 Thu Oct 2026 785.50 774.00 to 789.00 0.08% 1.23 times
21 Wed Oct 2026 784.90 779.45 to 808.95 -1.98% 0.69 times
19 Mon Oct 2026 800.75 778.75 to 809.75 1.97% 2.21 times
16 Fri Oct 2026 785.25 781.00 to 788.50 0.06% 0.31 times
15 Thu Oct 2026 784.80 780.00 to 787.75 0.23% 0.75 times
14 Wed Oct 2026 783.00 781.00 to 794.85 -0.84% 1.1 times
13 Tue Oct 2026 789.60 787.50 to 803.55 -1.32% 0.42 times
12 Mon Oct 2026 800.20 789.10 to 804.15 -2.85% 1.36 times
06 Tue Oct 2026 823.70 815.55 to 826.00 0.19% 0.92 times
05 Mon Oct 2026 822.15 801.35 to 827.65 0.05% 1.29 times
01 Thu Oct 2026 821.75 803.30 to 826.75 -2.63% 0.95 times
29 Tue Sep 2026 843.95 827.90 to 851.65 1.91% 1.02 times

Videos related to: 524816 announcements Natco Pharm announcements and dividends declared BSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

524816 announcements Natco Pharm announcements and dividends declared BSE

 

Back to top